Source · Prevention of Future Deaths

Neville McNair

Ref: 2019-0380 Date: 5 Nov 2019 Coroner: Fiona King Area: East Sussex Responses identified: 2 / 3 View PDF

Prison staff lacked training in recognising and responding to opiate overdose, including Naloxone administration. Naloxone was not readily available in all risk areas, and no clear local protocol existed for its use.

Date 5 Nov 2019
56-day deadline 31 Dec 2019
Responses identified 2 of 3
Hospital Death (Clinical Procedures and medical management) related deaths State Custody related deaths

Coroner's concerns

AI summary
Prison staff lacked training in recognising and responding to opiate overdose, including Naloxone administration. Naloxone was not readily available in all risk areas, and no clear local protocol existed for its use.
View full coroner's concerns
The MATTERS OF CONCERNS are as follows: In the Drug misuse and dependence: UK guidelines on clinical management “Orange Book” setting out UK guidelines on clinical management, section 5.4.9.1 states that ‘all staff including non-health care staff and operational/security staff should have training in recognising and responding to opiate overdose including using available Naloxone. Naloxone should be available in resuscitation kits and risk assessed areas in the prison so that it can be accessed and administered by clinical and non-clinical staff as per the local protocol.’ The Inquest was unable to establish that there was a local protocol and none of the prison staff were aware of the requirement. I am concerned that there is no Naloxone stored on the wings other than in healthcare wing and no prison officers appear to have been trained in its use or know of its existence. I believe this may be a national issue and not limited to HMP Lewes and in these circumstances this report should be seen as a concern for all prisons and NHS staff working in prisons nationally.

Responses

2 respondents
NHS England NHS / Health Body
5 Nov 2019 PDF
Action Taken

The Forward Trust provides substance misuse services at HMP Lewes and has a protocol for opioid overdose, with staff trained in naloxone administration. NHS England has developed a quality assurance framework to ensure quality standards are met in secure estate establishments and discussed concerns at the HMP Lewes Quality Board. (AI summary)

View full response
Dear Ms King,

Re: Regulation 28 Report to Prevent Future Deaths – Neville Lewis McNair (Date of Death 16th June 2018)

Thank you for your Regulation 28 Report dated 5th November 2019 concerning the death of Neville Lewis McNair on 16th June 2018. Firstly, I would like to express my deep condolences to Neville McNair’s family.

The regulation 28 report concludes Neville McNair’s death was a result of heroin toxicity with aspiration. Following the inquest, you raised concerns in your Regulation 28 Report to NHS England that the drug misuse and dependence: UK guidelines on clinical management “Orange Book” section 5.4.9.1 states that ‘all staff including non-healthcare staff and operational/security staff should have training in recognising and responding to opiate overdose including using available Naloxone. Naloxone should be available in resuscitation kits and risk assessed areas in the prison so that it can be accessed and administered by clinical and non-clinical staff as per the local protocol’.

The Inquest was unable to establish that there was a local protocol and none of the prison staff were aware of the requirement. You were concerned that there is no Naloxone stored on the wings other than the healthcare wing and no prison officers appeared to have been trained in its use or know of its existence. You believed this may be a national issue and not limited to HMP Lewes and in these circumstances believed the report should be a concern for all prisons and NHS staff working in prisons nationally.

In response to the matters raised I can confirm that the Forward Trust who are commissioned to provide substance misuse services in HMP Lewes have a protocol in place in line with national clinical guidelines for the handling of suspected opioid overdose and they have assured us that Healthcare staff have access to and are trained in the administration of naloxone in the prison. Naloxone is available for the first line treatment of suspected opioid overdose contained within the accessible

National Medical Director NHS England & NHS Improvement Skipton House 80 London Road London SE1 6LH

10th January 2020

‘grab bags’ used by staff at HMP Lewes in the event of the sudden deterioration or collapse of a prisoner. NHS England and NHS Improvement Regional Health and Justice commissioners continue to work with Forward Trust and Sussex Partnership NHS Trust to ensure that the healthcare services delivered in HMP Lewes follow the national guidance as part of their quality assurance which is overseen via the Local Delivery Quality Board, Contract Review and Partnership Boards. I can confirm that your concerns were discussed at the HMP Lewes Quality Board on 27th November. The governor at HMP Lewes who is the chair for this meeting has agreed to review the protocol. This issue has also raised concerns for NHS England and Improvement at the National level. The National Quality & Lead Nurse and the National Pharmaceutical Adviser both for Health and Justice have developed a quality assurance framework which has been sent to all Regional Commissioning teams. This will be used to assure themselves that all the quality standards in the National Clinical Guidelines are being met in all secure estate establishments. Where these are not being met an action plan will be developed and monitored by the regional commissioners via contract management processes. The results will also be presented to the local governance structures in time to go to the May 2020 National Quality Assurance Group (NQAG) where any additional work will be planned, and completion monitored. Thank you for bringing these important patient safety issues to my attention and please do not hesitate to contact me should you need any further information.
HM Prisons and Probation Service Central Government
6 Feb 2020 PDF
Action Planned

HMPPS is preparing a pilot project to train prison staff in a number of prisons in the north of England to administer naloxone, and is considering the use of alternatives to intramuscular naloxone, such as nyxoid. (AI summary)

View full response
Dear Ms King Thank you for your Regulation 28 Report of 5 November 2019, following the inquest into the death of Neville McNair at HMP Lewes on 16 June 2018. I am grateful to you for granting an extension to the statutory deadline for my response. I would first like to express my condolences to the family and friends of Mr McNair for their loss. The safety of those in our care is my absolute priority and every death in custody is a tragedy. You have raised a concern about the availability of naloxone in prison establishments, drawing attention to the ‘Orange Book’ guidelines on clinical management. I understand that Professor Powis has responded separately to confirm that NHS England and NHS Improvement (NHSE&I) are committed to ensuring that prison healthcare providers comply with the guidelines, and that the Governor of HMP Lewes has agreed to work with the local healthcare provider and commissioner to review the protocol at the prison. I am committed to working with NHSE&I to make naloxone more readily available across the prison estate. This is not straightforward, and there are risks to both staff and prisoners that need to be managed. For this reason, the current position is that it is being administered only by healthcare professionals. There are a number of issues that require further consideration before we can move forward to involve prison staff more widely. Identifying a potential opioid overdose and administering treatment for it has not previously been a part of the role of prison officers and other non-clinical staff in prisons, and we will need to consider precisely how this will work in practice, and what training we will need to provide to equip staff to take it on. We will also need to consult trade unions as we develop our approach. We are working to determine the best way of managing the risks. Consideration is being given to the use of alternatives to intramuscular naloxone, such as nyxoid, a nasal form of naloxone. We are also preparing a pilot project to train prison staff in a number of prisons in

the north of England. I will make sure that we continue to work with our health partners to take this forward as quickly as we can, whilst continuing to manage the risks to staff and prisoners. You may be interested to know that, in line with the clinical guidelines set out in the ‘Orange Book’, we have made naloxone more available to individuals in approved premises, and are issuing it to prisoners who are believed to be at high risk of overdose on release (e.g. those who have recently completed detoxification programmes). However, you will appreciate that we need to take the necessary time to establish the best way to protect both staff and prisoners from the risks associated with the deployment of naloxone before making it more broadly available within the custodial environment. Thank you again for raising this matter of concern with me. I hope that my response provides assurance that we are taking this seriously and committed to finding the best way to improve access to naloxone in prisons.

Report sections

Investigation and inquest
On 19/06/2018 I commenced an investigation into the death of Neville Lewis MCNAIR aged 51. The investigation concluded at the end of the inquest on 28 October 2019. The conclusion of the inquest was: I a Heroin toxicity with aspiration I b I c II
Circumstances of the death
Mr McNair was remanded into custody at HMP Lewes on 23rd March 2018 where he remained until his death on 16th June 2018. He was found unresponsive in his cell and was not able to be revived following extensive CPR emergency services. During the process of my investigation it was established that Mr McNair had accessed illegal heroin and had adapted an asthma inhaler in order to inhale it.
Action should be taken
7 YOUR RESPONSE You are under a duty to respond to this report within 56 days of the date of this report, namely by 31 December 2019. I, the coroner, may extend the period. Your response must contain details of action taken or proposed to be taken, setting out the timetable for action. Otherwise you must explain why no action is proposed. 8 COPIES and PUBLICATION I have sent a copy of my report to the Chief Coroner and to the following Interested Persons; the family of Mr McNair, Forward Trust, Sussex Partnership NHS Foundation Trust and Governor HMP Lewes. I am also under a duty to send the Chief Coroner a copy of your response. The Chief Coroner may publish either or both in a complete or redacted or summary form. He may send a copy of this report to any person who he believes may find it useful or of interest. You may make representations to me, the coroner, at the time of your response about the release or the publication of your response by the Chief Coroner. Fiona KING Assistant Coroner for East Sussex Dated: 05 November 2019

Similar PFD reports

Shared signals

Related inquiry recommendations

Similar themes

Report details

Reference
2019-0380
Date of report
5 November 2019
Coroner
Fiona King
Coroner area
East Sussex

Responses identified

Responses identified 2 of 3
1 response not yet linked

Organisations named in PFD reports are normally expected to respond within 56 days. Deadline: 31 Dec 2019.

Sent to

HM Prison and Probation Service
NHS England
NHS Improvement

Source links